Tops & Flops Stocks
Security | Change (%) ▲ | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Invitae Corp | -78.840% | - | - | - | - | - | - |
Ionis Pharmaceuticals Inc. | -2.680% | -0.215% | 4.224% | 28.504% | 1.577% | 50.227% | -19.629% |
Genomic Health | -2.270% | - | - | - | - | - | - |
Repligen Corp. | -2.040% | 2.907% | 7.735% | -19.335% | -23.956% | -37.155% | 50.330% |
Sage Therapeutics Inc. | -1.930% | -11.703% | -0.100% | -68.610% | -50.090% | -72.801% | -93.179% |
Blueprint Medicines Corp | -1.890% | -4.988% | 1.292% | 77.217% | 23.515% | 42.757% | 14.765% |
Iovance Biotherapeutics Inc. | -1.810% | 9.169% | 11.828% | 27.876% | 7.044% | -55.894% | -62.198% |
Ironwood Pharmaceuticals | -1.590% | 1.639% | 7.826% | -37.374% | -39.216% | -45.133% | -33.590% |
Agios Pharmaceuticals Inc. | -1.340% | 1.370% | 8.824% | 83.471% | 115.534% | 5.263% | 3.172% |
United Therapeutics | -1.320% | 1.374% | 4.205% | 39.236% | 56.267% | 99.871% | 340.057% |
Bluebird Bio Inc. | -1.250% | 8.612% | 23.162% | -68.557% | -9.948% | -94.803% | -99.086% |
Halozyme Therapeutics Inc. | -1.120% | 2.644% | 4.785% | 29.394% | 51.374% | 48.264% | 236.707% |
Amicus Therapeutics Inc. | -1.060% | -0.532% | 2.186% | -22.083% | -29.167% | 24.667% | -15.507% |
Neurocrine Bioscience | -1.040% | 0.487% | 4.317% | 45.224% | 12.406% | 71.527% | 72.011% |
Xencor Inc. | -1.020% | 10.857% | 9.605% | -9.346% | 1.571% | -27.232% | -50.799% |
Ligand Pharmaceuticals | -1.010% | 8.021% | 31.169% | 64.228% | 55.385% | -0.932% | 4.685% |
PTC Therapeutics Inc. | -0.650% | 2.013% | -4.403% | -16.484% | 20.635% | -6.748% | -26.151% |
Medpace Holdings Inc | -0.280% | -12.425% | -8.507% | 51.922% | 25.160% | 137.635% | 479.216% |
Arrowhead Pharmaceuticals Inc. | -0.110% | 2.498% | 10.025% | -16.316% | -5.291% | -53.634% | 3.673% |
Exelixis Inc. | -0.050% | 2.154% | 1.862% | 18.523% | -2.468% | 50.388% | 13.198% |
Mirati Therapeutics Inc. | -0.040% | - | - | - | - | - | - |
Catalent Inc. | 0.430% | 1.813% | 3.320% | 25.339% | 32.184% | -46.079% | 6.701% |
Ultragenyx Pharmaceutical Inc. | 0.480% | 3.980% | 8.854% | 8.854% | -3.687% | -38.074% | -24.344% |
Spark Therapeutics | 1.030% | - | - | - | - | - | - |
Charles River Labs Intl | 1.160% | 5.019% | 13.923% | 14.457% | 3.146% | -35.760% | - |